Seasonal Affective Disorder Global Clinical Trials Review, H2, 2016

Introduction

Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016" provides an overview of Seasonal Affective Disorder (SAD) clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Affective Disorder (SAD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016

• Table of Contents

  Table of Contents 2

  List of Tables 3

  List of Figures 3

  Report Guidance 4

  Clinical Trials by Region 5

  Clinical Trials and Average Enrollment by Country 6

  Top Countries Contributing to Clinical Trials in Europe 7

  Top Countries Contributing to Clinical Trials in North America 8

  Clinical Trials by G7 Countries: Proportion of Seasonal Affective Disorder (SAD) to Central Nervous System Clinical Trials 9

  Clinical Trials by Phase in G7 Countries 10

  Clinical Trials by Phase 11

  Clinical Trials by Trial Status 12

  Clinical Trials by End Point Status 13

  Subjects Recruited Over a Period of Time 14

  Clinical Trials by Sponsor Type 15

  Prominent Sponsors 16

  Top Companies Participating in Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials 17

  Clinical Trial Profile Snapshots 18

  Appendix 24

  Abbreviations 24

  Definitions 24

  Research Methodology 25

  Secondary Research 25

  About GlobalData 26

  Contact Us 26

  Disclaimer 26

  Source 27

List Of Tables
in Seasonal Affective Disorder Global Clinical Trials Review, H2, 2016

List of Tables

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials by Region, 2016* 5

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Europe, Top Countries, 2016* 7

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, North America, Top Countries, 2016* 8

Proportion of Seasonal Affective Disorder (SAD) to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 9

Seasonal Affective Disorder (SAD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 10

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials by Phase, 2016* 11

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 12

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 13

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 14

Seasonal Affective Disorder (SAD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 15

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 16

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 17

List Of Figures, Charts and Diagrams
in Seasonal Affective Disorder Global Clinical Trials Review, H2, 2016

List of Figures

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials by Region (%), 2016* 5

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 7

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 8

Proportion of Seasonal Affective Disorder (SAD) to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 9

Seasonal Affective Disorder (SAD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 10

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 11

Seasonal Affective Disorder (SAD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 12

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 13

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 14

Seasonal Affective Disorder (SAD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 15

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 16

Seasonal Affective Disorder (SAD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 17

GlobalData Methodology 25

Additional Details

Publisher

Global Data

Publisher Information

Reference

27173 | GDHC3578CTIDB

Number of Pages

27

Report Format

PDF

Related Reports